SP
Publicaties op Oncologisch.com
Palbociclib, Trastuzumab, and Endocrine Therapy in Pretreated HER2-Positive and PAM50 Luminal Gevorderd Breast Cancer...
Eerstelijns Camizestrant for Emerging ESR1-Mutated Gevorderd Breast Cancer.
Datopotamab Deruxtecan Versus Chemotherapy in Previously Treated Inoperable/Metastatic Hormone Receptor-Positive Huma...
High Mechanical Conditioning by Tumor Extracellular Matrix Stiffness Is a Predictive Biomarker for Antifibrotic Thera...
Palbociclib plus trastuzumab bij HER2-positief gevorderd mammacarcinoom: SOLTI-1303 PATRICIA fase II
Zevenjaars follow-up van adjuvant paclitaxel-trastuzumab bij kliernegatief HER2-positief mammacarcinoom: APT